NeoTherapeutics Inc.: The Irvine drug development company...

NeoTherapeutics Inc.: The Irvine drug development company lost $1.2 million, or 23 cents a share, for the second quarter, compared with a year-earlier loss of $197,286, or 7 cents a share. For the first six months the company lost $2 million, or 38 cents a share, compared with a loss of $270,699, or 11 cents a share, for the first six months of 1996. No revenue was reported. The company said the higher net loss was primarily due to increased expenditures for research and development and administration.